Fidelity® Series Intrinsic Opps (FDMLX)
14.95
+0.16 +1.08%
Jul 10
USD
Key Stats
| Expense Ratio | 0.01% |
| Total Assets Under Management | 11.62B |
| Share Class Assets Under Management | 11.62B |
| Net Asset Value | 14.95 |
| Turnover Ratio | 27.00% |
| 1 Year Fund Level Flows | -1.814B |
Performance & Returns
| Total Return | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|
| 1M | -4.90% | -6.12% | 22 |
| 3M | 10.33% | 7.03% | 19 |
| 6M | -12.93% | -20.13% | 10 |
| YTD | -13.58% | -20.68% | 10 |
| 1Y | -4.18% | -14.79% | 7 |
| 3Y | 2.04% | -1.85% | 8 |
| 5Y | 4.52% | 1.91% | 11 |
| 10Y | -- | 8.29% | -- |
| 15Y | -- | 5.63% | -- |
| 20Y | -- | 7.13% | -- |
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 9.08% | 9.08% | 0.00% |
| Stock | 90.90% | 90.90% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.02% | 0.02% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
Region Exposure
| Americas | 59.20% |
| North America | 58.81% |
| Latin America | 0.39% |
| Greater Europe | 10.73% |
| United Kingdom | 3.71% |
| Europe Developed | 7.00% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.02% |
| Greater Asia | 30.07% |
| Japan | 19.32% |
| Australasia | 0.72% |
| Asia Developed | 5.32% |
| Asia Emerging | 4.71% |
| Market Classification | |
| % Developed Markets | 95.11% |
| % Emerging Markets | 4.89% |
Stock Sector Exposure
| Basic Materials | 2.31% |
| Communication Services | 4.23% |
| Consumer Cyclical | 19.31% |
| Consumer Defensive | 5.40% |
| Energy | 7.47% |
| Financial Services | 15.75% |
| Healthcare | 27.15% |
| Industrials | 10.91% |
| Real Estate | 0.21% |
| Technology | 4.92% |
| Utilities | 2.33% |
Stock Market Capitalization
| Giant | 16.33% |
| Large | 27.68% |
| Medium | 28.68% |
| Small | 17.11% |
| Micro | 10.20% |
Stock Style Exposure
| Large Cap Value | 20.86% |
| Large Cap Blend | 22.01% |
| Large Cap Growth | 0.95% |
| Mid Cap Value | 21.11% |
| Mid Cap Blend | 4.96% |
| Mid Cap Growth | 2.81% |
| Small Cap Value | 14.53% |
| Small Cap Blend | 9.03% |
| Small Cap Growth | 3.73% |
View More Holdings
As of April 30, 2020
Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| ANTM | Anthem Inc | 6.14% | 261.17 | +2.42% |
| 8001 | ITOCHU Corp | 3.33% | -- | -- |
| AMGN | Amgen Inc | 3.20% | 251.28 | +0.90% |
| MET | MetLife Inc | 2.74% | 37.23 | +0.79% |
| UNH | UnitedHealth Group Inc | 2.35% | 297.15 | +2.03% |
| JD. | JD Sports Fashion PLC | 1.99% | -- | -- |
| UTHR | United Therapeutics Corp | 1.86% | 118.49 | +0.89% |
| CVS | CVS Health Corp | 1.73% | 62.75 | +0.16% |
| WU | The Western Union Co | 1.72% | 21.36 | +0.14% |
| SYF | Synchrony Financial | 1.60% | 22.63 | +0.31% |
Advertisement
Basic Info
| Investment Strategy | |
|---|---|
| The investment seeks capital appreciation. The fund invests primarily in common stocks. It invests in securities of companies that Fidelity Management & Research Company (FMR) believes are undervalued in the marketplace in relation to factors such as assets, sales, earnings, growth potential, or cash flow, or in relation to securities of other companies in the same industry (stocks of these companies are often called "value" stocks). The fund invests in domestic and foreign issuers. | |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FDMLX |
| Equity Style | Mid Cap/Value |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Mid-Cap Value |
| Prospectus Objective | Growth |
| Fund Owner Firm Name | Fidelity Investments |
| Benchmark Index | |
| Russell 3000 TR USD | 100.0% |
| Reports | |
| One Page Report | Download |
Manager Info
| Name | Tenure |
|---|---|
| Joel Tillinghast | 7.57 yrs |
Net Fund Flows
| 1M | -82.37M |
| 3M | -263.12M |
| 6M | -242.64M |
| YTD | -242.64M |
| 1Y | -1.814B |
| 3Y | -1.023B |
| 5Y | 3.433B |
| 10Y | -- |
Risk Info
| Beta (5Y) | 0.8984 |
| Historical Sharpe Ratio (10Y) | -- |
| Historical Sortino (All) | 0.6546 |
| Daily Value at Risk (VaR) 1% (All) | 2.39% |
| Monthly Value at Risk (VaR) 1% (All) | 14.12% |
Fundamentals
| Dividend Yield TTM (7-10-20) | 3.03% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Weighted Average PE Ratio | 8.747 |
| Weighted Average Price to Sales Ratio | 0.5044 |
| Weighted Average Price to Book Ratio | 0.9730 |
| Weighted Median ROE | 16.63% |
| Weighted Median ROA | 5.75% |
| Forecasted Dividend Yield | 3.23% |
| Forecasted PE Ratio | 10.73 |
| Forecasted Price to Sales Ratio | 0.4639 |
| Forecasted Price to Book Ratio | 0.8917 |
| Number of Holdings | 841 |
Growth Estimates
| Forecasted 5 Yr Earnings Growth | 7.30% |
| Forecasted Book Value Growth | 5.41% |
| Forecasted Cash Flow Growth | 5.70% |
| Forecasted Earnings Growth | 7.41% |
| Forecasted Revenue Growth | 5.55% |
Comparables
Edit| FFNPX | Fidelity® Flex Intrinsic Opps |
| JMVNX | JHFunds2 Mid Value NAV |
| FVUSA000S7 | EQ/Mid Cap Value Managed Volatil IB |
| GTTMX | Glenmede Quant US Total Market Equity |
| FLPSX | Fidelity® Low-Priced Stock |
Attributes
| Purchase Details | |
|---|---|
| Open to New Investors | No |
| Open to Existing Investors | Yes |
| Minimum Initial Investment | 0.00 USD |
| Minimum Subsequent Investment | 0.00 USD |
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.00% |
| Administration Fee | -- |
| Performance Fee | 0.20% |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| Key Dates | |
| Inception Date | 12/6/2012 |
| Termination Date | |
| Last Annual Report Date | 7/31/2019 |
| Last Prospectus Date | 9/28/2019 |
| Attributes | |
| Exchange Traded Share | No |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Fixed Distribution Fund | No |
| High-Net Worth Individual Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
Advertisement
